Day: May 15, 2020

Rovio Entertainment Oyj – Omien osakkeiden hankinta 15.05.2020Rovio Entertainment Oyj                             PÖRSSITIEDOTE                  15.05.2020 klo 18.45Helsingin PörssiPäivämäärä                                                15.05.2020Pörssikauppa                                             OstoOsakelaji                                                    ROVIOOsakemäärä                                               46706             osakettaKeskihinta/osake                                        5,422304         euroaKokonaiskustannus                                    253254,13       euroaYhtiön hallussa on 15.05.2020 tehtyjen kauppojen jälkeen 5 837 295 osaketta.Rovio Entertainment Oyj:n puolestaOP Yrityspankki OyjMarko Niemi                                Antti KerätärLisätietoja:Rene Lindell, talousjohtaja+358 207 888 300...

TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:Middlefield Canadian Income PCC1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsXAn acquisition or disposal of financial instrumentsAn event changing the breakdown of voting rightsOther (please specify)iii: This notification is being made solely as a result of the demerger of Prudential plc and M&G plc, resulting in a change of control from Prudential to M&G.X3. Details...

AttachmentGOFORE_15.5_trades

LiiteGOFORE_15.5_trades

LiiteOVARO_15.5_trades

NEW YORK, May 15, 2020 (GLOBE NEWSWIRE) — BOQI International Medical Inc. (NASDAQ: BIMI)  (“BIMI” or the “Company”) announced its financial results for the fiscal year ended December 31, 2019.Fiscal Year 2019 Financial Highlights:Revenues for the year ended December 31, 2019 and 2018 were $157,978 and $0, respectively.Cost of revenues for the year ended December 31, 2019 was $304,120.Net loss of $4,452,279 for the year ended December 31, 2019 compared to a net loss of $16,999,794 for the year ended December 31, 2018.Fiscal Year 2019 and Recent Operational Highlights:On October 14, 2019, the Company acquired Boqi Zhengji (the “Boqi Acquisition”), which operates a pharmacy chain business in the PRC, by purchasing 100% of the equity interests of Lasting, Boqi Zhengji’s parent company. The Boqi Acquisition was our first step of expansion...

– Preclinical data on AUTO5 in T cell lymphoma and solid tumor data on AUTO6NG in small cell lung cancer and AUTO7 in prostate cancer –Conference Call and Webcast to be held Thursday, June 25, 2020 at 8:30 am EDT / 1:30 pm BSTLONDON, May 15, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced poster presentations related to AUTO5 in T cell lymphoma and AUTO6NG in small cell lung cancer, as well as an oral presentation related to AUTO7 in prostate cancer at the American Association for Cancer Research (AACR) Virtual Annual Meeting II on Jun 22 – 24, 2020.Oral Presentation Title: AUTO7: Anti-PSMA humanized CAR T cell with improved persistence and resistance to tumor microenvironment for...

Kompletteringen avser avsaknaden av bifogad kallelse, denna är bifogad nu.Kallelse till årsstämma i ArcAroma AB (publ)Aktieägarna i ArcAroma AB (publ), 556586-1985, kallas härmed till årsstämma onsdagen den17 juni 2020 kl. 15.00 på Råbylunds Gård (www.rabylundsgard.se), Prästavägen 12, 224 78 Lund.Rätt att delta och anmälanAktieägare som önskar delta i årsstämman ska vara införd i den av Euroclear Sweden AB förda aktieboken torsdagen den 11 juni 2020 och anmäla sig till bolaget senast torsdagen den 11 juni 2020 skriftligen till ArcAroma AB, Skiffervägen 12, 224 78 Lund. Anmälan kan också göras per telefon 073 – 631 73 71 eller per e-post info@arcaroma.com. I anmälan ska fullständigt namn, person- eller organisationsnummer, aktieinnehav, adress och telefonnummer dagtid uppges, samt i förekommande fall ska även uppgift om biträden (högst...

CALGARY, Alberta, May 15, 2020 (GLOBE NEWSWIRE) — Pieridae Energy Limited (Pieridae or the Company) (TSXV: PEA) issued the following statement from CEO Alfred Sorensen with respect to the Alberta Energy Regulator’s (“AER”) decision to deny the application to transfer licences for Shell’s Foothills Assets to Pieridae: